Sucralfate Oral Suspension — Class I drug recall D-0047-2024
Terminated recall by VistaPharm LLC, reported 2023-10-25, distributed nationwide. Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
| Recall number | D-0047-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | VistaPharm LLC, Largo, FL, United States |
| Recall initiated | 2023-10-18 |
| Classified | 2023-10-16 |
| Reported by FDA | 2023-10-25 |
| Terminated | 2024-04-30 |
| Distributed | Nationwide (US) |
| Quantity | 180 bottles |
| Reason classes | microbial contamination, sterility |
| Pathogens | bacillus cereus |
| NDC | 66689-0305, 66689-0305-16 |
| Lot numbers | 810300 |
| Expiration dates | 2023-10 |
Product
Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16
Reason for recall
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0047-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.